PTPN22 and autoimmune disease: On the other hand, murine model studies have demonstrated that PTPN22 loss of function in myeloid cells results in an augmented inflammatory effector phase of autoimmune disease and GC generation by influencing the number and activity of Th follicular cells [44,45].